(Circulation. 1999;100:1380-1386.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Division of Cardiovascular Diseases and Internal Medicine (L.H.L., J.K.O., J.B.S., A.J.T.), the Division of Thoracic and Cardiovascular Surgery (H.V.S., G.K.D.), and the Section of Biostatistics (D.W.M.), Mayo Clinic and Mayo Foundation, Rochester, Minn. Dr Ling is now at the Cardiac Department, National University Hospital, 5 Lower Kent Ridge Rd, Singapore 119074.
| Abstract |
|---|
|
|
|---|
Methods and ResultsThe contemporary spectrum of CP in 135 patients (76% male) evaluated at the Mayo Clinic from 1985 to 1995 was compared with that of a historic cohort. Notable trends were an increasing frequency of CP due to cardiac surgery and mediastinal radiation and presentation in older patients (median age, 61 versus 45 years). Perioperative mortality decreased (6% versus 14%, P=0.011), but late survival was inferior to that of an age- and sex-matched US population (57±8% at 10 years). The long-term outcome was predicted independently by 3 variables in stepwise logistic regression analyses: (1) age, (2) NYHA class, and most powerfully, (3) a postradiation cause. Of 90 late survivors in whom functional class could be determined, functional status had improved markedly (2.6±0.7 at baseline versus 1.5±0.8 at latest follow-up [P<0.0001]), with 83% being free of clinical symptoms.
ConclusionsThe evolving profile of CP, with increasingly older patients and those with radiation-induced disease in the past decade, significantly affects postoperative prognosis. Long-term results of pericardiectomy are disappointing for some patient groups, especially those with radiation-induced CP. By contrast, surgery alleviates or improves symptoms in the majority of late survivors.
Key Words: pericarditis prognosis surgery
| Introduction |
|---|
|
|
|---|
We hypothesized that the observed changes in the clinical spectrum of CP influence postoperative prognosis in the current era. Because the epidemiology of CP is strongly influenced by geography and referral bias, changes in disease patterns are most appropriately defined vis-à-vis a historic cohort from the same institution. Accordingly, we reviewed the cases of patients with proven CP evaluated at the Mayo Clinic in the past decade and identified contemporary trends in relation to 231 patients examined at our institution from 1936 through 1982.4
| Methods |
|---|
|
|
|---|
During this period, 135 patients were identified: 133 at surgery and 2 at autopsy. Case histories were reviewed, and clinical findings by a staff cardiologist were recorded. Follow-up of patients was done with a mailed questionnaire, hospital records, and telephone calls to the patients, their relatives, and their physicians. The circumstances and causes of death recorded in death certificates were verified whenever possible with the patient's physician or the coroner who certified the death. Concomitant medical illnesses were assigned weights and summed as a comorbidity index for survival analyses.
Definitions
Radical pericardiectomy was defined as wide excision of
the pericardium anteriorly between the 2 phrenic nerves and from the
great arteries superiorly to the diaphragm inferiorly,
posterior to the left phrenic nerve (which is left on a pedicle) to the
left pulmonary veins, and including the pericardium on the
diaphragmatic and posterior surfaces of the ventricles.4
Constricting layers of epicardium were also removed. The atria and
venae cavae were decorticated only if the dissection could be
accomplished easily, without risk of
hemorrhage.4 5 Pericardiectomy was considered
partial if both ventricles could not be decorticated completely because
of dense myopericardial adhesions or calcification.
For uniformity with other studies, perioperative death was defined as that occurring within 30 days after surgery. However, all deaths within the same hospitalization as for surgery were included in analysis of predictors of perioperative death. Cardiac-related death was defined as death due to cardiac causes, such as progressive CHF or sudden death. Sudden unexpected death was defined according to the criteria of Hinkle and Thaler,6 whereas sudden expected death was abrupt death occurring in the setting of progressive CHF or an episode of CHF in the preceding 12 months. A poor cardiovascular outcome was defined as any combination of the end points of perioperative death, late cardiovascular death, and new-onset or recurrent New York Heart Association (NYHA) class III to IV CHF.
Statistical Analysis
Categorical data, expressed as percentages, were compared by the
t test or
2 test, as appropriate.
Continuous variables, expressed as mean±SD or median values, were
compared by the 2-sample Wilcoxon rank sum test. The rates of
all-cause mortality, perioperative death, late
survival, late cardiac-related death, recurrent NYHA class III to IV
CHF, and a poor late cardiovascular outcome were
estimated by the Kaplan-Meier method. Late survival curves were
compared with those of a normal 1990 US population matched for age and
sex by the log-rank test. Baseline predictors of subsequent sudden
death were identified by univariate Cox proportional
hazards analysis initially performed on candidate variables
(Table 1
). Variables
univariately significant on the basis of a threshold value
of P
0.15 were entered stepwise into a multivariable
logistic regression model to confirm independent predictive value. A
value of P<0.05 was considered statistically
significant.
|
| Results |
|---|
|
|
|---|
|
Patients who had received radiotherapy most commonly had Hodgkin's lymphoma (8 patients) or breast cancer (7 patients), a median of 13.1 years (range, 1.0 to 40.6 years) before pericardiectomy. Of the patients with connective tissue disease or arthritides, 6 had rheumatoid arthritis and 1 each had rheumatic fever (with myopericarditis), polymyalgia rheumatica, psoriatic arthropathy, and Still's disease. Infectious causes identified were fungal pericarditis (histoplasmosis and candidiasis) in 2 patients and tuberculosis and Whipple's disease in 1 patient each. Miscellaneous causes included myeloproliferative disorders, malignancy, trauma, asbestosis, drug-induced causes, and complicated pacemaker lead replacement. CP was diagnosed in 2 patients at autopsy: 1 had had cardiac surgery and the other had tumor encasement by non-Hodgkin's lymphoma.
Clinical Characteristics
Clinical characteristics of the study population are shown in
Table 2
. The presentation was
CHF in 90 patients (67%), chest pain in 11 (8%), abdominal symptoms
in 8 (6%), cardiac tamponade in 7 (5%), atrial arrhythmia in
6 (4%), and frank liver disease in 5 (4%). In the other 8 patients,
the initial presentation included postoperative low cardiac
output state, recurrent pleural effusion, transient ischemic
attack, and syncope. The median symptomatic duration before
pericardiectomy was 11.7 months (range, 3 days to 29.1 years).
Chronicity of symptoms characterized patients with an indeterminate
cause of CP (mean, 17.4 months).
|
Surgery
Pericardiectomy was performed in 132 of the 135 patients. One
patient who had previously had radiotherapy underwent triple
coronary artery bypass graft surgery and a tricuspid
annuloplasty, but the patient's condition deteriorated
intraoperatively and pericardiectomy was not performed. Radical
pericardiectomy was performed in 117 patients (89%). Pericardial
resection was deemed incomplete in the other 15 patients (11%).
Ultrasonic debridement of calcified pericardium was performed in 12
patients (9%), coronary artery bypass grafting was performed
in 10 patients (8%), valve replacement or repair in 5 (4%), and a
combined coronary artery-valve procedure, atrial septal defect
closure, resection of subaortic stenosis, and right
ventricular outflow tract enlargement in 1 patient (0.8%)
each. Cardiopulmonary bypass was used in 45 patients; the mean
extracorporeal circulation time was 88±58 minutes.
Overall Survival
Information about death was available for all except 1 patient
(99%) and for other end points in 129 patients (98%). In patients
dismissed from the hospital, the mean follow-up period was 3.9±3.0
years (maximum, 12.2 years). There were 39 deaths (30%), of which 26
occurred after hospital dismissal. At 5 and 10 years, overall survival
was 71±5% and 52±8%, respectively. Independent determinants of
overall survival were age, previous radiotherapy, NYHA class, and serum
concentration of sodium (Table 3
).
|
Perioperative Deaths
The 30-day perioperative mortality was 6% (8 of
132). This compares favorably with the 14%
perioperative mortality in the historic cohort
(
2=6.40, P=0.011). A total of 13
patients died in hospital. The principal causes of death were low
output state in 6 patients, sepsis in 3, uncontrolled
hemorrhage in 2, and renal failure and respiratory
insufficiency in 1 each. Of these 13 patients, pericardiectomy was
incomplete in 6 (univariate P<0.0001 for
prediction of perioperative death), and
cardiopulmonary bypass was required in 9.
Late Survival
At last follow-up, 93 of the 119 operative survivors (78.2%) were
alive. Survival at 5 and 10 years was 78±5% and 57±8%,
respectively, and was inferior to that of an age- and
sex-matched US population (log-rank P<0.001) (Figure 2
). This difference was not observed for
the historic cohort, which had an identical proportion of patients with
advanced NYHA symptoms.4 In stepwise
multivariate analysis, independent predictors
of late survival were age, NYHA class, and previous radiation (Table 3
and Figure 3
). The difference
from expected survival was still statistically significant even when
patients with radiation disease were excluded (log-rank
P=0.016) (Figure 2
).
|
|
Late Cardiovascular Deaths
The late deaths in 26 patients resulted from cardiac-related
causes in 17, pleuropulmonary disease in 2, noncardiac illness
in 6, and an unknown cause in 1. None of the patients who had radiation
therapy died of recrudescent neoplastic disease.
Cardiac-related deaths were due to progressive CHF in 14 patients (4
terminated in sudden expected death) and were sudden and unexpected in
3. The cumulative incidence of cardiovascular deaths
was 14±4% and 35±9% at 5 and 10 years, respectively. Independent
predictors of late cardiac-related deaths were previous radiotherapy,
NYHA class III to IV symptoms, and age (Table 3
).
Late NYHA Class III to IV CHF Symptoms
Recurrent or new NYHA class III to IV symptoms supervened in 37 of
119 patients (31%) at some stage of late follow-up. The median time to
onset of new or recurrent CHF symptoms was 7.1 months (range, 0.4 to
137.1 months). Three patients were reoperated on for recurrent CP.
The 5- and 10-year incidence of late NYHA class III to IV CHF,
25±5% and 41±9%, respectively, parallels that of late
cardiovascular deaths, consistent with the
observation that most severely symptomatic patients died
eventually of a cardiac-related cause. Multivariate
predictors of late CHF were age, radiation, and the presence of ascites
(Table 3
).
Of the 89 patients alive at latest follow-up with complete follow-up
information, 74 (83%) were either asymptomatic or mildly
symptomatic (Figure 4
). Mean
functional class was 2.6±0.7 at baseline, compared with 1.5±0.8 after
pericardiectomy (mean change, 1.1±0.9, P<0.0001).
|
Freedom From Poor Cardiovascular Outcome
Of 129 patients with complete follow-up information, 75 (58%)
were alive and free of CHF at latest follow-up. At 5 and 10 years,
70±5% and 43±8% of patients, respectively, were free of a poor
cardiovascular outcome. This end point occurred in 15
of 17 patients (88%) who had received radiation, including 13 deaths,
and in 31 of 112 patients (28%) without a radiation basis for CP
(P<0.0001). The dismal outcome for patients with radiation
disease was reflected in a 12±6% freedom from any
cardiovascular event by 5 years.
| Discussion |
|---|
|
|
|---|
The increasing importance of iatrogenic causes of CP2 3 7 8 9 is reflected in the marked decline in the proportion of indeterminate causes in the present series. Postoperative CP may not be as uncommon as previously believed.2 7 9 10 At the current level of 725 000 such procedures performed annually in the United States, a conservative 0.3% incidence could yield up to 2200 new cases annually. Therapeutic radiation could also remain a significant cause of pericardial disease. Cardiac structures are exquisitely sensitive to the effects of radiation, which often become manifest decades later.11 12 In addition, improved cancer cure rates have resulted in greater longevity and thus the likelihood of developing cardiovascular sequelae.13 Active tuberculous CP, present in 6.1% of patients in the series of McCaughan et al,4 was rare in our patients (0.7%). This declining trend is in contradistinction to recent reports from other geographic regions,14 15 16 emphasizing again the heterogeneity of disease patterns.
Operative Mortality
The decline in operative mortality at our institution from 25% in
the earlier half of this century5 to 6% at present
probably is related to improvements in surgical technique,
anesthesia, and postoperative care. Despite the inclusion
of older patients and those with radiation-induced CP, our results
compare favorably with the 6% to 19% rate of larger series published
after 1985.1 2 3 14 15 17
Late Survival
Unlike our earlier experience, late survival was
inferior to that of an age- and sex-matched control
population. The difference in survival was not entirely explained by
the increased prevalence of radiation-induced CP. Two reasons may
account for this observation. First, patients with CP often have
systemic or pleuropulmonary disease that increases the risk of
noncardiac-related deaths. However, comorbidity was not a significant
predictor of late survival in our study. Second, improved
perioperative management and medical therapy could have
deferred attrition in patients with associated myocardial disease. This
latter possibility is supported by 2 observations: (1) preoperative
NYHA class independently predicted late cardiac-related deaths
and (2) the survival curves diverged early, after only 18 months.
Late death occurred suddenly in 6 patients. Sudden death has been reported in the setting of CP18 and after pericardiectomy.1 5 19 Occult atherosclerotic coronary artery disease may be suspected, but the pericardial process can also obliterate epicardial vessels and cause myocardial ischemia.20 21 This is unlikely after pericardiectomy unless it was incomplete. In 2 of our patients with radiation disease, sudden death could have resulted from accelerated coronary atherosclerosis.8 22
Predictors of Late Events
All long-term outcomes were predicted consistently by 3
baseline variables: age, NYHA class, and a radiation cause for
CP.
A correlation between NYHA class and overall or late survival has been observed by us and others and is the basis for advocating early pericardiectomy.1 4 17 However, the effect of age on survival after pericardiectomy has not previously been apparent because of the uniformly young populations studied, especially from regions in which tuberculosis is endemic.1 4 14 23 24 The median age of our patients is at least a decade older than that in other series.1 4 14 19 20 25 26 27 28 29 30 Greater physician awareness and a comprehensive Doppler echocardiographic examination could have been instrumental in diagnosing CP in these older patients.31
Previous radiotherapy was the most powerful predictor of all outcome measures. The deleterious late effects of radiation on cardiac structures other than the pericardium have been well described.8 12 32 33 Pericardiectomy is more challenging because of mediastinal fibrosis, which limits complete resection,34 35 and postoperative recovery may be prolonged because of chest wall fibrosis. Long-term survival is also compromised by pulmonary interstitial disease, impaired immunological responses, and recurrent primary tumor or secondary neoplasms from chemotherapy. However, all deaths in our patients with radiation pericarditis were cardiac-related. Our study confirms the guarded long-term outcome of these patients, even if some derived initial symptomatic relief after pericardiectomy. The recognition of such poor-risk subgroups also facilitates objective comparisons of survival data. For instance, although Tirilomis et al17 reported a 5-year overall survival of 85% after pericardiectomy, the mean age of their patients was 44 years, and only 1 patient had radiation-induced CP.
Late Functional Status
Pericardiectomy provided excellent relief of symptoms in most late
survivors in our study. However, nearly one third of these patients
experienced either new or recurrent NYHA class III to IV symptoms at
some time during follow-up. This could be due to incomplete surgical
resection.36 37 38 In our study, incomplete pericardiectomy
was significantly associated with recurrence of late CHF in
univariate analysis. However, the majority of
patients in whom recurrent symptoms developed had had radical surgery.
The culprit pathophysiological mechanisms in these
instances are not well characterized but include immobilization
atrophy, myopericardial involvement by the same pathological process
(exemplified by radiation disease), or physical extension of
pericardial calcification into the
myocardium.20 39 40 41 Residual myocardial
fibrosis was likely in our patients who had recurrent CHF symptoms,
because (1) many had radiation-induced disease and (2) restrictive left
ventricular filling could be documented by serial
Doppler echocardiography in some
patients.31 42
Involvement of adjacent pleuropulmonary structures by the constrictive disease process39 and concomitant chronic obstructive lung disease limited functional recovery in nearly a fifth of patients. Clearly, these mechanisms are not mutually exclusive in individual cases.
Limitations
Selecting cases of CP on the basis of thoracotomy findings
to reflect incidence represents a bias of all surgical
studies. It is likely that more cases remain unoperated on, because of
underdiagnosis, minimal symptoms, or high operative risk. However,
inspection of the pericardium remains the gold standard for the
diagnosis of CP and may be the only way to prove the diagnosis in
relation to restrictive
cardiomyopathy.31 43
Incomplete functional recovery in some patients may be the result of gradual adaptation of the released ventricles to loading conditions and may not represent the permanent functional state. However, nearly all our patients had follow-up of at least 1 year, and myocardial recovery should have occurred by that time.44 45
Unlike other investigators,1 we did not include cardiac catheterization variables for prediction of outcome. This test, which was done in 65 of the 132 patients, is currently not performed routinely in the workup of CP at our institution unless echocardiographic findings are nondiagnostic.
Because patients who had concomitant surgical procedures were excluded from our historic cohort, a direct comparison of outcome between the historic and contemporary patient groups may preferentially favor the former. However, the occasional need for concomitant coronary artery bypass graft surgery and valvular procedures did not have significant impact on early and late mortality in univariate analyses, consistent with the findings of other studies.29 36
Conclusions
CP is a heterogeneous disease. Increasingly important
causes in the current era include previous mediastinal irradiation and
cardiac surgery. Although pericardiectomy is often performed, it may
not offer a cure or good long-term result for patients with CP that is
advanced or due to radiation disease. Cardiac transplantation could be
considered in selected patients without recurrent tumor and with good
pulmonary reserve, particularly if severe
valvular disease coexists. However, postoperative prognosis and
functional outcomes remain good for most other patients with CP and
excellent for younger patients without radiation pericarditis.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received December 8, 1998; revision received June 28, 1999; accepted July 7, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. R. Talreja, R. A. Nishimura, J. K. Oh, and D. R. Holmes Constrictive Pericarditis in the Modern Era: Novel Criteria for Diagnosis in the Cardiac Catheterization Laboratory J. Am. Coll. Cardiol., January 22, 2008; 51(3): 315 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gongora, J. A. Dearani, T. A. Orszulak, H. V. Schaff, Z. Li, and T. M. Sundt III Tricuspid Regurgitation in Patients Undergoing Pericardiectomy for Constrictive Pericarditis Ann. Thorac. Surg., January 1, 2008; 85(1): 163 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Sengupta, V. K. Krishnamoorthy, W. P. Abhayaratna, J. Korinek, M. Belohlavek, T. M. Sundt III, K. Chandrasekaran, F. Mookadam, J. B. Seward, A. J. Tajik, et al. Disparate Patterns of Left Ventricular Mechanics Differentiate Constrictive Pericarditis From Restrictive Cardiomyopathy J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 29 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R.J. H. Bird and S. M. Swain Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems Clin. Cancer Res., January 1, 2008; 14(1): 14 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Enriquez-Sarano, V. T. Nkomo, and H. Michelena Principles and Practice of Echocardiography in Cardiac Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 315 - 348. [Full Text] |
||||
![]() |
A. A. Mangi and D. F. Torchiana Pericardial Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1465 - 1478. [Full Text] |
||||
![]() |
E. L Ivens, B. I Munt, and R. R Moss Pericardial disease: what the general cardiologist needs to know Heart, August 1, 2007; 93(8): 993 - 1000. [Full Text] [PDF] |
||||
![]() |
H. Yamada, T. Tabata, S. J. Jaffer, J. K. Drinko, S. E. Jasper, M. S. Lauer, J. D. Thomas, and A. L. Klein Clinical features of mixed physiology of constriction and restriction: Echocardiographic characteristics and clinical outcome Eur J Echocardiogr, June 1, 2007; 8(3): 185 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Babuin, J. R. Alegria, J. K. Oh, R. A. Nishimura, and A. S. Jaffe Brain Natriuretic Peptide Levels in Constrictive Pericarditis and Restrictive Cardiomyopathy J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1489 - 1491. [Full Text] [PDF] |
||||
![]() |
W. C. Little and G. L. Freeman Pericardial Disease Circulation, March 28, 2006; 113(12): 1622 - 1632. [Full Text] [PDF] |
||||
![]() |
U. K. Chowdhury, G. K. Subramaniam, A. S. Kumar, B. Airan, R. Singh, S. Talwar, S. Seth, P. K. Mishra, K. K. Pradeep, S. Sathia, et al. Pericardiectomy for Constrictive Pericarditis: A Clinical, Echocardiographic, and Hemodynamic Evaluation of Two Surgical Techniques Ann. Thorac. Surg., February 1, 2006; 81(2): 522 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Afanasyeva, D. Georgakopoulos, D. Fairweather, P. Caturegli, D. A. Kass, and N. R. Rose Novel Model of Constrictive Pericarditis Associated With Autoimmune Heart Disease in Interferon-{gamma}-Knockout Mice Circulation, November 2, 2004; 110(18): 2910 - 2917. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wakamatsu, T. Koizumi, K. Urushihata, K. Fujimoto, S. Uchikawa, K. Kubo, A. Iwamura, and M. Yazawa Direct Pericardial Involvement of Non-small Cell Lung Cancer Rapidly Developing Pericardial Constriction Jpn. J. Clin. Oncol., October 1, 2004; 34(10): 627 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
Recurrent pleural effusions, resistant atrial arrhythmias, and abnormal liver function tests: general medicine or cardiology? Heart, October 1, 2004; 90(10): 1228 - 1228. [Full Text] [PDF] |
||||
![]() |
A. Wang and T. M. Bashore Undercover and Overlooked N. Engl. J. Med., September 2, 2004; 351(10): 1014 - 1019. [Full Text] [PDF] |
||||
![]() |
J. A. Crestanello, C. G. A. McGregor, G. K. Danielson, R. C. Daly, J. A. Dearani, T. A. Orszulak, C. J. Mullany, F. J. Puga, K. J. Zehr, C. Schleck, et al. Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy Ann. Thorac. Surg., September 1, 2004; 78(3): 826 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Bertog, S. K. Thambidorai, K. Parakh, P. Schoenhagen, V. Ozduran, P. L. Houghtaling, B. W. Lytle, E. H. Blackstone, M. S. Lauer, and A. L. Klein Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1445 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
Task Force members, B. Maisch, P. M. Seferovic, A. D. Ristic, R. Erbel, R. Rienmuller, Y. Adler, W. Z. Tomkowski, G. Thiene, M. H. Yacoub, et al. Guidelines on the Diagnosis and Management of Pericardial Diseases Executive Summary: The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology Eur. Heart J., April 1, 2004; 25(7): 587 - 610. [Full Text] [PDF] |
||||
![]() |
R. S. Schofield, S. B. Shoemaker, E. G. Ryerson, G. R. Cooper, and W. D. Spotnitz Left ventricular dysfunction after pericardiectomy for constrictive pericarditis Ann. Thorac. Surg., April 1, 2004; 77(4): 1449 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Sagrista-Sauleda Pericardial constriction: uncommon patterns Heart, March 1, 2004; 90(3): 257 - 258. [Full Text] [PDF] |
||||
![]() |
J. Sagrista-Sauleda, J. Angel, A. Sanchez, G. Permanyer-Miralda, and J. Soler-Soler Effusive-Constrictive Pericarditis N. Engl. J. Med., January 29, 2004; 350(5): 469 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Haley, A. J. Tajik, G. K. Danielson, H. V. Schaff, S. L. Mulvagh, and J. K. Oh Transient constrictive pericarditis: causes and natural history J. Am. Coll. Cardiol., January 21, 2004; 43(2): 271 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
|